Pitch session

The following selected pitch presenters will share their innovative project results, technologies, products or services contributing to the development of next generation vaccines and immunotherapy:

• Perjan Pleunis - LivingMed Biotech :

Tackling the next potential pandemic at the source, using needle-free feed based vaccines

• Benjamin Damien - Sagitta Biotech :

Hybrid Viral Vector/mRNA platform able to elicit good immune response from a constant manufacturing process

• Sabine den Roover - Vrije Universiteit Brussel:

LAPIS: Crafting Precision in Therapeutic Delivery, One Layer at a Time

• Cato Leenders - KU Leuven:

Detection of infection risk and immune response to vaccination

• Colas Soldan - Poulpharm BV:

Tailored Autogenous Vaccines for Animal Health: From GMP-like Production to R&D Innovation

• Lorenzo Franceschini - Vrije Universiteit Brussel:

Developing synthetic RNA for the rapid selection of next-generation personalized therapeutics

• Benjamin Boinem - Inokura:

The indomitable gauls : Deep in the hills of Wallonia a small village of Indomitable gauls still performs clinical trials.

• Moises Maestro - Puxano:

Innovative Antigen Design: Generating soluble analogues of membrane protein antigens